Concepedia

Francesco Galimi

FG

36

Publications

5.4K

Citations

29

H-Index

1993

Active since

Affiliations

University of Turin(Current)

Candiolo Cancer Institute

Amgen (United States)

Amgen (United Kingdom)

Department of Medical Sciences

Francesco Galimi is an author at University of Turin specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1993–2024

36

Publications

36

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi et al. · Cancer Discovery · 2011 · 938 citations · Full text

Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Alberto Bardelli, Simona Corso, Andrea Bertotti et al. · Cancer Discovery · 2013 · 654 citations · Full text

, , +17

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Claudio Isella, Francesco Brundu, Sara E. Bellomo et al. · Nature Communications · 2017 · 316 citations · Full text

Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3

Chong Sun, Sebastijan Hobor, Andrea Bertotti et al. · Cell Reports · 2014 · 309 citations · Full text

HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment

Shyam M. Kavuri, Naveen Jain, Francesco Galimi et al. · Cancer Discovery · 2015 · 286 citations · Full text

Rows per page

1–5 of 36